Dihydropyridine-sensitive calcium channels and barbiturate tolerance and withdrawal.
We have shown previously that the dihydropyridine calcium channel antagonist nitrendipine, given chronically, prevents the development of ethanol tolerance and physical dependence. The present study examines the effects on barbiturate tolerance and physical dependence. Nitrendipine, given acutely during withdrawal, provided little protection against barbiturate withdrawal, as measured by convulsive behaviour on handling. When nitrendipine was given chronically concurrently with the barbiturate, a prolonged protection against the withdrawal syndrome was seen. Acute nitrendipine significantly increased the latency of seizures in response to the partial benzodiazepine inverse agonist FG7142 during barbiturate withdrawal, but there was no effect on the seizure incidence in response to bicuculline. Chronic treatment with nitrendipine did not alter the development of tolerance to the ataxic or general anaesthetic actions of barbiturates, but evidence was found of a possible interaction between nitrendipine and pentobarbitone, which may have been pharmacokinetic. The results suggest that neuronal calcium channels may be involved to some degree in the development of the changes responsible for barbiturate withdrawal, but to a less extent than found previously for ethanol dependence.
Rabbani
M
M
Pharmacology Department, Medical School, Bristol, U.K.
Brown
J
J
Butterworth
A R
AR
Little
H J
HJ
D000768:Anesthesia, General; D000818:Animals; D001259:Ataxia / Q000139:chemically induced; D001463:Barbiturates / Q000494:pharmacology*; D001640:Bicuculline / Q000494:pharmacology; D015220:Calcium Channels / Q000187:drug effects*; D002243:Carbolines / Q000494:pharmacology; D004095:Dihydropyridines / Q000494:pharmacology*; D004361:Drug Tolerance; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009568:Nitrendipine / Q000494:pharmacology / Q000627:therapeutic use; D010424:Pentobarbital / Q000494:pharmacology; D012640:Seizures / Q000139:chemically induced / Q000503:physiopathology; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control* / Q000523:psychology
D001463:Barbiturates; D015220:Calcium Channels; D002243:Carbolines; D004095:Dihydropyridines; C035874:FG 7142; D009568:Nitrendipine; D010424:Pentobarbital; D001640:Bicuculline